»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ ½ÃÀåÀº 2024³âºÎÅÍ 2029³â±îÁö 3¾ï 3,830¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È 7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ(HIV Rapid Test Kit) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¿¡ ´ëÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº HIV °Ë»ç¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í ÇÁ·Î±×·¥ Áõ°¡, HIV ÇöÀå °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, HIVÀÇ ³ôÀº À¯º´·ü¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
YOY 2025
6%
CAGR
7%
Áõ°¡¾×
3¾ï 3,830¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³âµ¿¾È Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î È¥Àü ¿¡ÀÌÁî °ËÁøÀ» ´Ã¸®±â À§ÇÑ ³ë·ÂÀ» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, ¿¬±¸ÀÚµéÀÇ ÀÓ»ó ¿¬±¸ Áõ°¡¿Í Á¦Á¶¾÷üµéÀÇ È«º¸ Ȱµ¿, ±â¾÷µéÀÇ ´Ù¾çÇÑ HIV ½Å¼Ó °Ë»ç ŰƮ Á¦°øÀº ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð(2024³â)
½ÃÀå Àü¸Á(2024-2029³â)
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå(2019-2023³â)
À¯Åë ä³Îº° ºÎ¹® ºÐ¼®(2019-2023³â)
À¯Çüº° ºÎ¹® ºÐ¼®(2019-2023³â)
ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼®(2019-2023³â)
¼Ò½ºº° ºÎ¹® ºÐ¼®(2019-2023³â)
Áö¿ªº° ºÎ¹® ºÐ¼®(2019-2023³â)
±¹°¡º° ºÎ¹® ºÐ¼®(2019-2023³â)
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ¼¼°èÀÇ Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀï À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : À¯Åë ä³Îº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Åë ä³Îº°
¿ÀÇÁ¶óÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿Â¶óÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : À¯Åë ä³Îº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Çüº°
HIV ½Å¼Ó ¸é¿ªÃøÁ¤ °Ë»ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
HIV ½Å¼Ó ºÐÀÚÁø´Ü °Ë»ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : À¯Çüº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
Áø´Ü¼¾ÅÍ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
º´¿ø ¹× Áø·á¼Ò : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦11Àå ½ÃÀå ¼¼ºÐÈ : ¼Ò½ºº°
½ÃÀå ºÎ¹®
ºñ±³ : ¼Ò½ºº°
Ç÷¾× : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
±¸°¾× : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¼Òº¯ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ¼Ò½ºº°
Á¦12Àå °í°´ »óȲ
Á¦13Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Çѱ¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦14Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ
Á¦15Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦16Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Abbott Laboratories
AccuQuik Test Kits
Becton Dickinson and Co.
bioLytical Laboratories Inc.
bioMerieux SA
Chembio Diagnostics Inc.
Danaher Corp.
DrSafeHands
F. Hoffmann La Roche Ltd.
Fujirebio Holdings Inc.
Healgen Scientific, LLC
Hologic Inc.
J. Mitra and Co. Pvt. Ltd.
MP Biomedicals Inc.
OraSure Technologies Inc.
Á¦17Àå ºÎ·Ï
LSH
The human immunodeficiency virus (HIV) rapid test kits market is forecasted to grow by USD 338.3 million during 2024-2029, accelerating at a CAGR of 7% during the forecast period. The report on the human immunodeficiency virus (HIV) rapid test kits market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in awareness programs for HIV testing, growing demand for point-of-care testing for HIV, and high prevalence of HIV.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 6%
CAGR 7%
Incremental Value $338.3 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's human immunodeficiency virus (HIV) rapid test kits market is segmented as below:
By Distribution Channel
By Type
HIV rapid immunoassay test
HIV rapid molecular diagnostic test
By End-user
Diagnostic centers
Hospitals and clinics
By Source
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the efforts to increase pre-marital screenings for HIV as one of the prime reasons driving the human immunodeficiency virus (HIV) rapid test kits market growth during the next few years. Also, increasing clinical studies by researchers and promotional activities by manufacturers and availability of a broad range of HIV rapid test kits by companies will lead to sizable demand in the market.
The report on the human immunodeficiency virus (HIV) rapid test kits market covers the following areas:
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market sizing
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market forecast
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human immunodeficiency virus (HIV) rapid test kits market vendors that include Abbott Laboratories, AccuQuik Test Kits, Amkay Products Pvt. Ltd., Becton Dickinson and Co., Bhat Bio Tech India Pvt Ltd., bioLytical Laboratories Inc., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DrSafeHands, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Healgen Scientific, LLC, Hologic Inc., J. Mitra and Co. Pvt. Ltd., MP Biomedicals Inc., Oragenics Inc., OraSure Technologies Inc., Pathkits, and SHINE SA. Also, the human immunodeficiency virus (HIV) rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Source
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2019 - 2023
Historic Market Size - Data Table on Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2019 - 2023 ($ million)
5.2 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Source segment analysis 2019 - 2023
Historic Market Size - Source Segment 2019 - 2023 ($ million)
5.6 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.7 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the global human immunodeficiency virus (HIV) rapid test kits market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel
8.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
8.3 Offline - Market size and forecast 2024-2029
Chart on Offline - Market size and forecast 2024-2029 ($ million)
Data Table on Offline - Market size and forecast 2024-2029 ($ million)
Chart on Offline - Year-over-year growth 2024-2029 (%)
Data Table on Offline - Year-over-year growth 2024-2029 (%)
8.4 Online - Market size and forecast 2024-2029
Chart on Online - Market size and forecast 2024-2029 ($ million)
Data Table on Online - Market size and forecast 2024-2029 ($ million)
Chart on Online - Year-over-year growth 2024-2029 (%)
Data Table on Online - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 HIV rapid immunoassay test - Market size and forecast 2024-2029
Chart on HIV rapid immunoassay test - Market size and forecast 2024-2029 ($ million)
Data Table on HIV rapid immunoassay test - Market size and forecast 2024-2029 ($ million)
Chart on HIV rapid immunoassay test - Year-over-year growth 2024-2029 (%)
Data Table on HIV rapid immunoassay test - Year-over-year growth 2024-2029 (%)
9.4 HIV rapid molecular diagnostic test - Market size and forecast 2024-2029
Chart on HIV rapid molecular diagnostic test - Market size and forecast 2024-2029 ($ million)
Data Table on HIV rapid molecular diagnostic test - Market size and forecast 2024-2029 ($ million)
Chart on HIV rapid molecular diagnostic test - Year-over-year growth 2024-2029 (%)
Data Table on HIV rapid molecular diagnostic test - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by End-user
10.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Diagnostic centers - Market size and forecast 2024-2029
Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)
10.4 Hospitals and clinics - Market size and forecast 2024-2029
Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
11 Market Segmentation by Source
11.1 Market segments
Chart on Source - Market share 2024-2029 (%)
Data Table on Source - Market share 2024-2029 (%)
11.2 Comparison by Source
Chart on Comparison by Source
Data Table on Comparison by Source
11.3 Blood - Market size and forecast 2024-2029
Chart on Blood - Market size and forecast 2024-2029 ($ million)
Data Table on Blood - Market size and forecast 2024-2029 ($ million)
Chart on Blood - Year-over-year growth 2024-2029 (%)
Data Table on Blood - Year-over-year growth 2024-2029 (%)
11.4 Oral fluids - Market size and forecast 2024-2029
Chart on Oral fluids - Market size and forecast 2024-2029 ($ million)
Data Table on Oral fluids - Market size and forecast 2024-2029 ($ million)
Chart on Oral fluids - Year-over-year growth 2024-2029 (%)
Data Table on Oral fluids - Year-over-year growth 2024-2029 (%)
11.5 Urine - Market size and forecast 2024-2029
Chart on Urine - Market size and forecast 2024-2029 ($ million)
Data Table on Urine - Market size and forecast 2024-2029 ($ million)
Chart on Urine - Year-over-year growth 2024-2029 (%)
Data Table on Urine - Year-over-year growth 2024-2029 (%)
11.6 Market opportunity by Source
Market opportunity by Source ($ million)
Data Table on Market opportunity by Source ($ million)
12 Customer Landscape
12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
13.10 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
13.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
13.12 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.13 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
13.14 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
13.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
13.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
Overview on factors of disruption
15.4 Industry risks
Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
16.2 Company ranking index
16.3 Market positioning of companies
Matrix on companies position and classification
16.4 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT
16.5 AccuQuik Test Kits
AccuQuik Test Kits - Overview
AccuQuik Test Kits - Product / Service
AccuQuik Test Kits - Key offerings
SWOT
16.6 Becton Dickinson and Co.
Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
SWOT
16.7 bioLytical Laboratories Inc.
bioLytical Laboratories Inc. - Overview
bioLytical Laboratories Inc. - Product / Service
bioLytical Laboratories Inc. - Key offerings
SWOT
16.8 bioMerieux SA
bioMerieux SA - Overview
bioMerieux SA - Product / Service
bioMerieux SA - Key offerings
SWOT
16.9 Chembio Diagnostics Inc.
Chembio Diagnostics Inc. - Overview
Chembio Diagnostics Inc. - Product / Service
Chembio Diagnostics Inc. - Key news
Chembio Diagnostics Inc. - Key offerings
SWOT
16.10 Danaher Corp.
Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus
SWOT
16.11 DrSafeHands
DrSafeHands - Overview
DrSafeHands - Product / Service
DrSafeHands - Key offerings
SWOT
16.12 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
16.13 Fujirebio Holdings Inc.
Fujirebio Holdings Inc. - Overview
Fujirebio Holdings Inc. - Product / Service
Fujirebio Holdings Inc. - Key offerings
SWOT
16.14 Healgen Scientific, LLC
Healgen Scientific, LLC - Overview
Healgen Scientific, LLC - Product / Service
Healgen Scientific, LLC - Key offerings
SWOT
16.15 Hologic Inc.
Hologic Inc. - Overview
Hologic Inc. - Business segments
Hologic Inc. - Key news
Hologic Inc. - Key offerings
Hologic Inc. - Segment focus
SWOT
16.16 J. Mitra and Co. Pvt. Ltd.
J. Mitra and Co. Pvt. Ltd. - Overview
J. Mitra and Co. Pvt. Ltd. - Product / Service
J. Mitra and Co. Pvt. Ltd. - Key offerings
SWOT
16.17 MP Biomedicals Inc.
MP Biomedicals Inc. - Overview
MP Biomedicals Inc. - Product / Service
MP Biomedicals Inc. - Key offerings
SWOT
16.18 OraSure Technologies Inc.
OraSure Technologies Inc. - Overview
OraSure Technologies Inc. - Business segments
OraSure Technologies Inc. - Key news
OraSure Technologies Inc. - Key offerings
OraSure Technologies Inc. - Segment focus
SWOT
17 Appendix
17.1 Scope of the report
17.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
17.3 Currency conversion rates for US$
Currency conversion rates for US$
17.4 Research methodology
17.5 Data procurement
17.6 Data validation
17.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
17.8 Data synthesis
17.9 360 degree market analysis
360 degree market analysis
17.10 List of abbreviations